A complete qPCR kit for the detection of AmpC beta-lactamase (ACT/MIR) Resistance
AMPC BETA-LACTAMASE (ACT/MIR) RESISTANCE: AMPC Beta-Lactamase is an antibiotic resistance marker commonly found in bacteria, causing infections in humans and animals. Failure to detect this resistance marker early can lead to treatment failure and the spread of resistant strains, posing a significant threat to public health in the medical and veterinary sectors.
YouSeq's qPCR kit to detect AMPC Beta-Lactamase allows for sensitive and specific identification of this resistance marker, enabling timely intervention and appropriate antibiotic treatment. Early detection can help prevent the spread of resistant bacteria, improve patient outcomes, and reduce the economic burden of antibiotic resistance in healthcare and agriculture.
Available for delivery in United States
Price on enquiry
Order nowFor Research Use Only. Not intended for diagnostic use.
Contents
Endogenous control primer/probe
qPCR MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer
ROX passive reference
Technical specification
Efficiency: 90-110%
Run Time: Approx 1hr30 (dependent on instrumentation)
Target Marker: FAM labelled
Endogenous Control: VIC/HEX labelled
Product variants
YS-ABR-ACT/MIR-100 : Frozen version for dry ice shipping
Pseudonyms
AMPC Beta-Lactamase (ACT/MIR) Resistance; Gram-negative bacteria; Superbugs; Multi-drug resistant organisms; Carbapenem-resistant organisms; CRE; Extended-spectrum beta-lactamase (ESBL) producers; Vancomycin-resistant Enterococci (VRE); Methicillin-resistant Staphylococcus aureus (MRSA); Mycobacterium tuberculosis; Clostridium difficile